Breaking News
Upgrade 0
💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair Value Learn More
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
71.8400 +0.8700    +1.23%
11:38:59 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
WKN:  885823
  • Volume: 570
  • Bid/Ask: 71.7900 / 71.8600
  • Day's Range: 70.9800 - 71.8400
Gilead 71.8400 +0.8700 +1.23%

GILD Balance Sheet

 
Featured here, the Balance Sheet for Gilead Sciences Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
30/06
2024
31/03
2023
31/12
2023
30/09
Total Current Assets 12317 14041 16085 15980
Cash and Short Term Investments 3781 5524 8350 7974
Cash - - - -
Cash & Equivalents 2772 4718 6085 5705
Short Term Investments 1009 806 2265 2269
Total Receivables, Net 4663 4669 4660 4790
Accounts Receivables - Trade, Net 4663 4669 4660 4790
Total Inventory 2026 1853 1787 1663
Prepaid Expenses 1374 1422 1281 1495
Other Current Assets, Total 473 573 7 58
Total Assets 53579 56292 62125 62373
Property/Plant/Equipment, Total - Net 5346 5321 5898 5572
Property/Plant/Equipment, Total - Gross - - 8347 -
Accumulated Depreciation, Total - - -2449 -
Goodwill, Net 8314 8314 8314 8314
Intangibles, Net 22832 23428 26454 27152
Long Term Investments 706 1144 2159 1737
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 4064 4044 3215 3618
Other Assets, Total -1155 -1437 -601 -800
Total Current Liabilities 10781 13015 11280 11945
Accounts Payable 537 622 550 586
Payable/Accrued - - - -
Accrued Expenses 4775 5018 5003 4675
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1810 3667 1923 1793
Other Current liabilities, Total 3659 3708 3804 4891
Total Liabilities 35382 38837 39376 40131
Total Long Term Debt 21540 21527 23189 23189
Long Term Debt 21540 21527 23189 23189
Capital Lease Obligations - - - -
Deferred Income Tax 907 933 1588 1984
Minority Interest -84 -84 -84 -72
Other Liabilities, Total 2238 3446 3403 3085
Total Equity 18197 17455 22749 22242
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1 1 1 1
Additional Paid-In Capital 7022 6813 6500 6279
Retained Earnings (Accumulated Deficit) 11165 10656 16304 16002
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 9 -15 -56 -40
Total Liabilities & Shareholders' Equity 53579 56292 62125 62373
Total Common Shares Outstanding 1246 1246 1246 1247
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Giuseppe Giannachi
Giuseppe Giannachi Jun 20, 2024 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The news seems amazing. 100% AIDS prevention...?
Maria Kenny
Maria Kenny Jun 11, 2024 9:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Acquisition decreased EPS. This has 40% upside by January 2025. Hold. Do not sell.
Luis Anderson
Luis Anderson Jul 14, 2023 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to buy
Bugman CV
Bugman CV Apr 28, 2022 1:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Who cares about dividends when this stock shows weakness year after year, is not a good deal to get 5% per year if you are constantly worried about this stock sinks under 2013 lows
Jorge Almeida Pereira
Jorge Almeida Pereira Apr 28, 2022 1:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Are you a coinbase client?
Luis Anderson
Luis Anderson Apr 28, 2022 1:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Keith Chan
Keith Chan Mar 08, 2022 10:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it sucks...
Dale Le
Dale Le Feb 17, 2022 9:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
invest stock gild.us at basel markets to take home divedends
Manny Drake
Manny Drake Jan 28, 2022 3:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Projected earnings beat but I'd bet it doesn't move the needle -
Tedeski Rukker
Tedeski Rukker Jan 07, 2022 6:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Another 15 or so shares into this.
Ted Trukker
Ted Trukker Nov 19, 2021 2:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I've held this since 2014 or so. COULD have picked NVDA for approx 15 - 20 😒Did I pick the winner eh?
BIG John
BIG John Oct 29, 2021 9:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Amazing how GILD managed to disappoint on EVERY earnings report.
Ted Trukker
Ted Trukker Oct 29, 2021 9:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes, even a beat is disapointing -
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email